Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy G Brusselle

Showing results (1-10 of 229) with videos related to

Pageof 23
Sort By:
Thorax|April 15, 2015
Are the antimicrobial properties of macrolides required for their therapeutic efficacy in chronic neutrophilic airway diseases?Guy G Brusselle
The New England Journal of Medicine|December 19, 2009
Matrix metalloproteinase 12, asthma, and COPDGuy G Brusselle
Lancet (London, England)|September 8, 2022
Classification of COPD: fostering prevention and precision medicine in the Lancet Commission on COPDGuy G Brusselle, Marc Humbert
The Lancet. Respiratory Medicine|September 7, 2016
Using a bronchial airway gene expression classifierKarim Vermaelen, Guy G Brusselle
The Lancet. Respiratory Medicine|April 19, 2021
Mepolizumab for chronic rhinosinusitis with nasal polypsGuy G Brusselle, Philippe Gevaert
Current Opinion in Pulmonary Medicine|November 20, 2013
Is there a role for macrolides in severe asthma?Guy G Brusselle, Guy Joos
Pulmonary Pharmacology & Therapeutics|October 2, 2014
Risk of a biased assessment of the evidence when limiting literature searches to the English language: macrolides in asthma as an illustrative exampleGuy G Brusselle, Francesco Blasi
The European Respiratory Journal|April 2, 2015
ERS guidelines, statements and technical standards published in the ERJ in 2014: a year in reviewGuy G Brusselle, Mina Gaga
Respirology (Carlton, Vic.)|November 27, 2019
Simultaneous inhibition of thymic stromal lymphopoietin, IL-33 and IL-25: A therapeutic option in asthma?Tania Maes, Guy G Brusselle
The European Respiratory Journal|December 17, 2013
Trustworthy guidelines on severe asthma thanks to the ERS and ATSGuy G Brusselle, Monica Kraft
Pageof 23

Showing results (1-10 of 229) with videos related to

Sort By:
Pageof 23
Thorax|April 15, 2015
Are the antimicrobial properties of macrolides required for their therapeutic efficacy in chronic neutrophilic airway diseases?Guy G Brusselle
The New England Journal of Medicine|December 19, 2009
Matrix metalloproteinase 12, asthma, and COPDGuy G Brusselle
Lancet (London, England)|September 8, 2022
Classification of COPD: fostering prevention and precision medicine in the Lancet Commission on COPDGuy G Brusselle, Marc Humbert
The Lancet. Respiratory Medicine|September 7, 2016
Using a bronchial airway gene expression classifierKarim Vermaelen, Guy G Brusselle
The Lancet. Respiratory Medicine|April 19, 2021
Mepolizumab for chronic rhinosinusitis with nasal polypsGuy G Brusselle, Philippe Gevaert
Current Opinion in Pulmonary Medicine|November 20, 2013
Is there a role for macrolides in severe asthma?Guy G Brusselle, Guy Joos
Pulmonary Pharmacology & Therapeutics|October 2, 2014
Risk of a biased assessment of the evidence when limiting literature searches to the English language: macrolides in asthma as an illustrative exampleGuy G Brusselle, Francesco Blasi
The European Respiratory Journal|April 2, 2015
ERS guidelines, statements and technical standards published in the ERJ in 2014: a year in reviewGuy G Brusselle, Mina Gaga
Respirology (Carlton, Vic.)|November 27, 2019
Simultaneous inhibition of thymic stromal lymphopoietin, IL-33 and IL-25: A therapeutic option in asthma?Tania Maes, Guy G Brusselle
The European Respiratory Journal|December 17, 2013
Trustworthy guidelines on severe asthma thanks to the ERS and ATSGuy G Brusselle, Monica Kraft
Pageof 23